ICLR ICON PLC
Industrials · Commercial Physical & Biological Research · Market cap: $14.6B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $4.0M |
| 2026-Q4 | $0 | $2.2M |
Bought$00 buy days
Sold$6.2M17 sell days
Net insider flow-$6.2Mnet selling · 5 years
Latest trade2026-11-02Balfe Barry Edward
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | Sell | Balfe Barry Edward | CEO | 5,175 | $206.66 | $1.1M | 5 |
| 2026-11-02 | Sell | Murray Ciaran | Director | 3,452 | $205.66 | $710.0K | 1 |
| 2026-11-02 | Sell | Clerkin Nigel Bernard John | CFO | 1,488 | $206.66 | $307.5K | 5 |
| 2026-11-02 | Sell | Lyons Emer | Other C-suite | 264 | $206.66 | $54.6K | 5 |
| 2026-10-23 | Sell | Lyons Emer | Other C-suite | 272 | $182.37 | $49.6K | 5 |
| 2026-09-17 | Sell | Murphy Ronan Martin | Director | 5,005 | $175.00 | $875.9K | 1 |
| 2026-09-17 | Sell | McCague Eugene Pacelli | Director | 3,255 | $175.00 | $569.6K | 1 |
| 2026-09-16 | Sell | CLIMAX JOHN DR | Director | 5,005 | $175.00 | $875.9K | 1 |
| 2026-08-11 | Sell | Murray Ciaran | Director | 2,677 | $164.29 | $439.8K | 4 |
| 2026-08-11 | Sell | Clerkin Nigel Bernard John | CFO | 2,267 | $164.29 | $372.4K | 4 |
| 2026-08-11 | Sell | O'Neill Julie | Director | 915 | $164.29 | $150.3K | 4 |
| 2026-08-11 | Sell | Grais Linda | Director | 841 | $164.29 | $138.2K | 4 |
| 2026-08-11 | Sell | CLIMAX JOHN DR | Director | 841 | $164.29 | $138.2K | 4 |
| 2026-08-11 | Sell | Whitaker Anne Clem | Director | 841 | $164.29 | $138.2K | 4 |
| 2026-08-11 | Sell | McCague Eugene Pacelli | Director | 841 | $164.29 | $138.2K | 4 |
| 2026-08-11 | Sell | Murphy Ronan Martin | Director | 841 | $164.29 | $138.2K | 4 |
| 2026-08-10 | Sell | Balfe Barry Edward | CEO | 382 | $164.07 | $62.7K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Murray Ciaran | Director | $0 | $1.1M | 2026-11-02 |
| Balfe Barry Edward | CEO | $0 | $1.1M | 2026-11-02 |
| CLIMAX JOHN DR | Director | $0 | $1.0M | 2026-09-16 |
| Murphy Ronan Martin | Director | $0 | $1.0M | 2026-09-17 |
| McCague Eugene Pacelli | Director | $0 | $707.8K | 2026-09-17 |
| Clerkin Nigel Bernard John | CFO | $0 | $679.9K | 2026-11-02 |
| O'Neill Julie | Director | $0 | $150.3K | 2026-08-11 |
| Grais Linda | Director | $0 | $138.2K | 2026-08-11 |
| Whitaker Anne Clem | Director | $0 | $138.2K | 2026-08-11 |
| Lyons Emer | Other C-suite | $0 | $104.2K | 2026-11-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.